Breaking News

0 426
Arena Pharmaceuticals, Inc. ARNA Stock News

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)

Arena Pharmaceuticals is having an overwhelmingly strong day in the market today. As soon as the trading session started for the day, the stock was already trading well into the green. Since the open of the session, the stock has remained relatively flat, but the gains seem to be here to stay. Below, we’ll talk about what we’re seeing from the stock, why, and what we’ll be watching for ahead.





What We’re Seeing From ARNA

As mentioned above, Arena Pharmaceuticals is having an overwhelmingly strong day in the market today. At the opening bell, the stock was already trading well into the green. Since the open of the session, we haven’t seen much movement, but all in all, the gains seem to be here to stay. At the moment (11:50), ARNA is trading at $1.60 per share after a gain of $0.18 per share or 12.68% thus far today.

Why The Stock Is Headed Upward

As is generally the case, our partners at Trade Ideas were the first to inform us of the gains on ARNA. As soon as we received the alert, the CNA Finance team started working to see why the stock was making a run for the top. It didn’t take long to dig up the story. Ultimately, the gains we’re seeing today are the result of earnings news.




Yesterday, after the closing bell, Arena Pharmaceuticals released its financial results for the fourth quarter and full year. Here’s what we saw from the report…

  • Revenue – Revenue for the quarter came in at $85.4 million. That’s a great number when you consider that for the full year, revenue only totaled $124 million.
  • Earnings Per Share – While revenue was positive, it wasn’t the only positive data that was released from the report. Earnings proved to be overwhelmingly positive for ARNA as well. While the company did produce a loss of $0.09 for the full year, that loss was brought down to size by earnings of $0.16 per share that were brought in during the fourth quarter.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on ARNA. In particular, we’re going to be watching for any news associated with continued growth. Also, since milestone payments played a key role in the fourth quarter, we’ll be keeping an eye on any future payments to come. Nonetheless, we’ll continue to follow the story and bring you the news as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Pixabay]

0 709
Catalyst Pharmaceuticals Inc CPRX Stock News

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX)

Catalyst Pharmaceuticals is having an incredibly strong day in the market today, following up on gains that we’ve seen on the stock since yesterday. The stock started the day slightly in the green, and throughout the day, has continued upward. Below, we’ll talk about what we’re seeing from CPRX, why, and what we’ll be watching for ahead.





What We’re Seeing From CPRX

As mentioned above, Catalyst Pharmaceuticals is having a relatively strong day in the market today. At the opening bell, the stock was already trading well into the green. Since then, we’ve seen a continuation of gains, bringing the stock further and further into the gains. At the moment (11:17), the stock is trading at $1.64 per share after a gain of $0.47 per share or 40.02% thus far today.

Why The Stock Is Climbing

First and foremost, we’d like to extend a thank you to our friends at Trade Ideas for being the first to inform us of the gains. With that said, as soon as we received the alert, the CNA Finance team started digging to see why the stock was making a run for the top. While there has been no news released today with regard to the stock, we do believe that we found the reason for the gains.




Ultimately, the gains are the result of news that broke yesterday. Yesterday, investors learned that Catalyst Pharmaceuticals has teamed up with Biocept Inc (NASDAQ: BIOC). The partnership surrounds liquid biopsy testing for small cell lung cancer. With Biocept’s success in that arena, it only makes sense that investors in CPRX would be excited about the partnership.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on CPRX. In particular, we’re watching the ongoing work surrounding liquid biopsy testing in the partnership with Biocept. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Wikimedia]

Nike Inc NKE Stock News

Nike Inc (NYSE: NKE)

Nike is having an interesting day in the market today to say the least. At the opening bell, the stock was trading well into the green. However, shortly after the bell, the stock started to slide. Then, minutes ago, the stock spiked downward into the red. Below, we’ll talk about what we’re seeing from NKE, why, and what we’ll be watching for ahead.





What We’re Seeing From NKE

As mentioned above, Nike isn’t having the best of days in the market today by any means. While the stock did start the day off well into the green, shortly after the bell, it started to slide in a big way. Then, minutes ago, it spiked down into the red. At the moment (10:49), NKE is trading at $57.14 per share after a loss of $0.13 per share or 0.24% thus far today.

Why The Stock Is Falling

We’re going to dig into the details here, but before we do, we’d like to extend a big thank you to Trade Ideas for being the first to bring the spike to our attention. When the CNA Finance team received the alert, we started digging to see why the stock was falling. It didn’t take long to dig up the story. Ultimately, the declines are the result of a rumor.




The rumor surrounding Nike is all over social media at the moment. The rumor is that the company’s offices in China are currently being inspected by Chinese Officials. Who those officials might be and what they’re looking for is not included in the rumor, nor has the rumor been confirmed. Nonetheless, it is leading to concerns among investors.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on NKE. In particular, we’ll be watching for any news surrounding the rumor that Chinese officials are investigating the company’s offices. Nonetheless, we’ll continue to follow the story closely and bring you the news as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required











[Image Courtesy of Pixabay]

0 3494
Cerulean Pharma Inc CERU Stock News

Cerulean Pharma Inc (NASDAQ: CERU)

Cerulean Pharma is having an incredible day in the market today. At the opening bell, the stock was already trading slightly in the green. Since then, we’ve seen a continuation of gains in the value of the stock, making investors more and more thrilled with the gains. Below, we’ll talk agbout what we’re seeing from the stock, why, and what we’ll be watching for ahead.





What We’re Seeing From CERU

As mentioned above, Cerulean Pharma is having an overwhelmingly strong day in the market today. At the opening bell, the stock was already trading slightly green, but those gains proved to be just the tip of the iceberg as the stock started to climb dramatically just after the bell. Currently (10:33), CERU is trading at $3.26 per share after a gain of $1.02 per share (45.42%) thus far today.

Why The Stock Is Making A Run For The Top

As is normally the case, our partners at Trade Ideas were the first to alert us to the upward movement on CERU. As soon as we received the alert, the CNA Finance team started working to see why the stock was making a run for the top. It didn’t take long to dig up the story. Ultimately, the gains are the result of acquisition hopes.




It all goes back to February 1st. On this day, the company put out a release stating that it is exploring potential alternatives, including the sale of the company, a possible merger, a business combination, a strategic investment into the company, a sale, license or disposition of assets of the company.

At the moment, the gains seem to be the result of rumors surrounding Cerulean Pharma that center around this release. The rumors are that the company has found the alternative they’re looking for and will likely be acquired soon. However, there has been no confirmation as of yet.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on CERU. In particular, we’re watching for any news associated with the potential acquisition, as strong value will be returned to shareholders if the rumors are valid. We’ll continue to follow the story closely and bring you the updates as they break!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Public Domain Pictures]

0 684
Digital Power Corporation DPW Stock News

Digital Power Corporation (NYSEMKT: DPW)

Digital Power Corporation is having an incredibly strong start to the trading session today. Thanks to massive gains in the pre-market, the stock started the day off trading at more than double yesterday’s closing price. While it has dipped down a bit since the open, the stock is still trading at incredibly impressive gains. Below, we’ll talk about what we’re seeing, why, and what we’ll be watching for with regard to DPW ahead.





What We’re Seeing From DPW

As mentioned above, Digital Power Corporation is having an incredibly strong start to the trading session today. At the opening bell, the stock was already trading on massive gains thanks to strong pre-market activity. Since then, it has dipped a bit, but not by much. At the moment (9:48), DPW is trading at $1.17 per share after a gain fo $0.58 per share or 98.31% thus far today.

Why The Stock Is Climbing

Before we get too deep into the details here, we need to give credit where credit is due. Our partners at Trade Ideas were the first to inform us of the gains on DPW. As soon as we received the alert, the CNA Finance team started working to see why the stock was making a run for the top. It didn’t take long to dig up the story. The gains have to do with a massive purchase order received by the company.




Early this morning, Digital Power Corporation announced that it had been awarded a 3 year, $50 million purchase order. The order was placed by MTIX Ltd and surrounds the manufacture, instalation and servicing of textile treatment systems. In a statement, Mr. Amos Kohn, the President and CEO at DPW had the following to offer…

This purchase order represents a significant business step by the Company since the order will enhance our power solution core technology business, as well as open new market opportunities… Because of our well-established international engineering and manufacturing capabilities. Digital Power Corporation is the perfect partner for MTIX Ltd. We will leverage our UK based subsidiary, Digital Power Limited, to manufacture, install and service the initial systems in the order for U.K./European based customers. Our expertise with power solution systems for the commercial and defense markets works well for the design of the MLSE(TM) system, which has components that include a sophisticated plasma and energy system…”

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on DPW. In particular, we’re going to be watching as this contract unfolds to see if any developments break. Nonetheless, we’ll continue to follow the story and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Wikipedia]

Msci Inc MSCI Stock News

Msci Inc (NYSE: MSCI)

Msci Inc is having an incredible day in the pre-market hours today. Early this morning, news with regard to a potential takeover hit the wire, exciting investors. Since then, we’ve seen incredibly strong upward movement on the stock. Below, we’ll talk about what we’re seeing from MSCI, why, and what we’ll be watching for ahead.





What We’re Seeing From MSCI

As mentioned above, Msci Inc is having an very good time in the market at the moment. While the market hasn’t yet opened for the day, the stock is trading up in a big way. In fact, MSCI is currently (9:16)trading at $108.50 per share after a gain of $12.57 per share (12.63%) thus far today.

Why The Stock Is Headed Up

As is nearly always the case, our partners at Trade Ideas were the first to alert us to the upward movement on MSCI. As soon as we received the alert, the CNA Finance team started digging to see why the stock was running for the top. In this particular case, the news pretty much jumped out at us. Ultimately, it has to do with a takeover offer.

At the moment, a rumor is coming down the wire that S&P Global offered to takeover MSCI. However, the news also says that MSCI has rejected the offer. Nonetheless, the news is exciting investors and causing the stock to climb.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on MSCI. In particular, we’re watching to see if anything changes with regard to the potential takeover. We’ll continue to follow the story and bring the news to you as it breaks!

Update 10:55 – MSCI has been halted on the news and there is said to be more news pending. The halt happened at 10:55 when the stock was trading at $105.76 per share after a gain of $9.43 per share (9.79%) thus far today. We will continue to watch the story closely and bring the news to you as it breaks!

Update 11:19 – MSCI issues a statement with regard to the news above. According to the statement, this is all rumors. Here’s what the company had to offer:

“We do not normally comment on rumors in the market, but in response to recent media reports regarding third party interest in MSCI, we believe such reports are incorrect. We are not in discussion with any third party, and we have not received any offer or indication of interest. We do not anticipate making any further comment regarding these rumors.”

Update 12:15 – MSCI has given up most of the early morning gains surrounding takeover speculation. However, it seems to have hit the bottom on its ride down and looks to be holding onto a small piece of the profits. Currently the stock is trading at $98.43 per share after a gain of $2.10 per share (2.18%) thus far today.

Update 11:27 – MSCI resumes. The stock is currently trading at $98.78 per share after a gain of $2.45 per share (2.54%) thus far today.

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Flickr]

Macy's Inc M Stock News

Macy’s Inc (NYSE: M)

Macy’s is off to a relatively interesting day in the market today. At the opening bell, the stock was trading slightly in the red before spiking upward and falling back to the red, where it spent the first hour or so of the day. From there, the stock made it to the green, and then minutes ago it spiked back down to the breakeven point. Below, we’ll talk about what we’re seeing from M, why, and what we’ll be watching for ahead.





What We’re Seeing From M

As mentioned above, Macy’s isn’t having the best of days in the market today. When the trading session started for the day, the stock was in the red before quickly spiking to the green. From there, it spiked back down to the red, where it has spent most of the morning. While it did hit the green recently, M quickly fell back to the breakeven point, where it sits as we speak (10:43).

Why The Stock Is Erratic

As is almost always the case, our partners at Trade Ideas were the first to inform us of the movement on M. As soon as they did, the CNA Finance team went to work to see what was causing the movement. It didn’t take long to dig up the story. It seems like a hedge fund has turned its focus away from the company and investors have mixed feelings.




Minutes ago, Hudson Bay Hedge Fund announced that it is turning its focus away from Macy’s and considering the purchase of Neiman Marcus. The hedge fund was expected to acquire the company some time down the road, but has decided that Neiman Marcus represents a better opportunity. As a result, M stock is working to find a direction as investors aren’t quite sure how they feel about the news.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on M stock. In particular, we’re interested in seeing if the company is considering reaching out to other potential suitors for the possibility of an acquisition. We’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Wikimedia]

0 790
Anthera Pharmaceuticals ANTH Stock News

Anthera Pharmaceuticals (NASDAQ: ANTH)

Anthera Pharmaceuticals is having an overwhelmingly rough day in the market today. After announcing a public offering in the after-hours yesterday, the stock went on a steep dive, causing it to open on an exceptionally low note today. Below, we’ll talk about the offering, what we’re seeing from the stock, and what we’ll be watching for with regard to ANTH ahead.





ANTH Prices Offering Of 30 Million Shares

As mentioned above, Anthera isn’t having the best of days in the market today. Before we get too deep into why, we would like to thank our partners at Trade Ideas for being the first to inform us of the losses on the stock. As soon as we received the alert, the CNA Finance team started digging to see why the stock was making a run for the bottom. It didn’t take long to dig up the dirt. It seems as though the declines are the result of dilution concerns.




In an announcement made after the closing bell yesterday, ANTH announced that it would be issuing a secondary public offering. The goal of the offering is to raise a total of $15 million. To do so, the company will be selling 30 million shares at a price of about $0.50 per share. Of course, this proved to be concerning to investors. After all, secondary public offerings are a main source of dilution in the market and never something that investors want to see.

What We’re Seeing From The Stock

As investors and traders, one of the first things that we learn is that the news moves the market, and this case is proving to be no different. Unfortunately, the secondary public offering has left a bad taste in investors’ mouths, leading to massive declines in the value of the stock. Currently (10:14), ANTH is trading at $0.42 per share after a loss of $0.26 per share (38.23%) thus far today.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on ANTH. In particular, we’re interested in learning more about how the funds raised from this offering will be allocated. We’ll continue to follow the story closely and bring any developments to you as they break!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Flickr]

Air Methods Corp AIRM Stock News

Air Methods Corp (NASDAQ: AIRM)

Air Methods is having a relatively strong day in the market today. At the opening bell, the stock was trading slightly up. From there, it continued upward for a short while before trading flat. Below, we’ll talk about what we’re seeing from AIRM, why, and what we’ll be watching for with regard to the stock moving forward.





What We’re Seeing From AIRM

As mentioned above, Air Methods Corp is having a relatively strong day in the market. After starting the day slightly in the territory of gains, the stock continued on an upward trend for the first few minutes. Since then, it has traded relatively flat. At the moment (9:49), AIRM is trading at $42.85 per share after a gain of $1.45 per share or 3.50% thus far today.

Why The Stock Is Headed Upward

Before we dive too deep into the story here, I’d like to give a big thank you to Trade Ideas for being the first to alert us of the gains on AIRM. When the CNA Finance team received the alert about the gains, we started digging to see why the stock was running for the top. It didn’t take long at all to uncover the story. The gains are ultimately the result of acquisition news.




Early this morning, it was announced that affiliates of American Securities LLC have decided to acquire the company. A definitive agreement was signed, under which American Securities LLC would pay $43.00 per share in cash for the acquisition. In a statement, Aaron Todd, CEO at AIRM had the following to offer…

This transaction will enable us to continue to execute against our strategy and strengthen our market position as a global leader in air medical transportation and air tourism… American Securities offers us a great opportunity to continue to invest and pursue long-term growth with greater operational flexibility, and we look forward to working with such a sophisticated private equity investor. Importantly, patients, employees, customers and partners will continue to benefit as we execute against our strategy.”

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be watching AIRM incredibly closely. While watching, we’ll be looking for further news surrounding this acquisition as it is still subject to customary closing conditions. Nonetheless, we do expect for the acquisition to go well without delay. We’ll continue to follow the story and bring you any developments as they break!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Wikimedia]

Ruby Tuesday, Inc. RT Stock News

Ruby Tuesday, Inc. (NYSE: RT)

Ruby Tuesday is having an incredibly strong start to the trading session today. In the pre-market hours, news was announced that caused excitement within the investing community. As a result, the stock started to climb in a big way. Below, we’ll talk about what we’re seeing from RT, why, and what we’ll be watching for with regard to the stock ahead.





What We’re Seeing From RT

As mentioned above, today is proving to be a strong day for Ruby Tuesday. Since early in the pre-market hours, the stock has been headed upward. At the moment, the gains seem to be continuing. At the moment (9:32), RT is trading at $2.00 per share after a gain of $0.26 per share or 14.94% thus far today.

Why The Stock Is Headed Up

As is almost always the case, the news that RT was making a run for the top was first brought to us by our partners at Trade Ideas. As soon as we received the alert, the CNA Finance team started working to see why the stock was rocketing toward the top. It didn’t take long to dig up the story. The gains are ultimately the result of merger/acquisition hopes.




Early this morning, it was announced that Ruby Tuesday may be interested in selling itself. In fact, the company is currently working to explore the possibility of a sale, a merger, or other strategic options. Of course, this caused excitement among the investing community as these options would likely generate incredible value for shareholders. As a result, investors pushed the value of the stock upward.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on RT. In particular, we’re interested in learning whether or not the company will be selling or merging. If not, what other strategic opportunities are being explored? Nonetheless, we’ll continue to follow the story closely and bring the news to you as it evolves.

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Wikimedia]

Thought Leader Discussions

Gevo, Inc. GEVO Stock News

0 5140
Gevo, Inc. (NASDAQ: GEVO) Before we get into this interview, I'd like to extend a special thanks to my friend Joey who both set up the...